COVID-19 pandemic - find out how we are supporting the research community

4th May 2020 / Updated 8th June 2020


At this unusual and challenging time I would like to express solidarity with you – our readers, authors, reviewers and Editorial Board Members.

All of our journal teams are currently home-based and we are adapting to new ways of working to minimise the impact on our authors, reviewers and Editorial Board Members. But we are very aware that the COVID-19 pandemic is causing significant disruption, and we know that you may have difficulty in meeting the timelines associated with our peer review process during normal times. If you need additional time to submit a revision or a reviewer report, please contact us.

At Springer Nature we taking a coordinated approach to help researchers, health professionals and policymakers tackle the virus and its effects by opening up access to all relevant content that we publish (see our Covid-19 content hub).

To help you carry on with your research, whatever your discipline, we are ensuring that library users have remote access to content. For more, see this message from Springer Nature's CEO, Frank Vrancken Peeters.

We are currently welcoming submissions on a rolling basis to our COVID-19 Collection which brings together advances in the tools being developed to combat the pandemic – from methods of detection, to potential treatment – updates relating to current events and epidemiological research, and insights into the virus' origin, evolution and biology. You can also look at some of the COVID-19 preprints currently undergoing peer review at Scientific Reports, on our Under Consideration website.

We are extremely grateful for your support, and all of us at Scientific Reports wish you well.

Richard White
Chief Editor, Scientific Reports